|
1
|
Dominguez-Brauer C, Thu KL, Mason JM,
Blaser H, Bray MR and Mak TW: Targeting mitosis in cancer: Emerging
strategies. Mol Cell. 60:524–536. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
DeLuca JG, Gall WE, Ciferri C, Cimini D,
Musacchio A and Salmon ED: Kinetochore microtubule dynamics and
attachment stability are regulated by Hec1. Cell. 127:969–982.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ciferri C, Pasqualato S, Screpanti E,
Varetti G, Santaguida S, Dos Reis G, Maiolica A, Polka J, De Luca
JG, De Wulf P, et al: Implications for kinetochore-microtubule
attachment from the structure of an engineered Ndc80 complex. Cell.
133:427–439. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tooley J and Stukenberg PT: The Ndc80
complex: Integrating the kinetochore's many movements. Chromosome
Res. 19:377–391. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hu P, Chen X, Sun J, Bie P and Zhang LD:
siRNA-mediated knockdown against NUF2 suppresses pancreatic cancer
proliferation in vitro and in vivo. Biosci Rep. 35(pii):
e001702015.PubMed/NCBI
|
|
6
|
Fu HL and Shao L: Silencing of NUF2
inhibits proliferation of human osteosarcoma Saos-2 cells. Eur Rev
Med Pharmacol Sci. 20:1071–1079. 2016.PubMed/NCBI
|
|
7
|
Xing XK, Wu HY, Chen HL and Feng HG: NDC80
promotes proliferation and metastasis of colon cancer cells. Genet
Mol Res. 15:2016. View Article : Google Scholar
|
|
8
|
Suzuki A, Badger BL, Haase J, Ohashi T,
Erickson HP, Salmon ED and Bloom K: How the kinetochore couples
microtubule force and centromere stretch to move chromosomes. Nat
Cell Biol. 18:382–392. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wan X, Huang W, Yang S, Zhang Y, Pu H, Fu
F, Huang Y, Wu H, Li T and Li Y: Identification of
androgen-responsive lncRNAs as diagnostic and prognostic markers
for prostate cancer. Oncotarget. 7:60503–60518. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chang KH, Li R, Kuri B, Lotan Y, Roehrborn
CG, Liu J, Vessella R, Nelson PS, Kapur P, Guo X, et al: A
gain-of-function mutation in DHT synthesis in castration-resistant
prostate cancer. Cell. 154:1074–1084. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang P, Gao K, Tang Y, Jin X, An J, Yu H,
Wang H, Zhang Y, Wang D, Huang H, et al: Destruction of DDIT3/CHOP
protein by wild-type SPOP but not prostate cancer-associated
mutants. Hum Mutat. 35:1142–1151. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
An J, Ren S, Murphy SJ, Dalangood S, Chang
C, Pang X, Cui Y, Wang L, Pan Y, Zhang X, et al: Truncated ERG
oncoproteins from TMPRSS2-ERG fusions Are resistant to
SPOP-mediated proteasome degradation. Mol Cell. 59:904–916. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang L, Wang J, Wang Y, Zhang Y, Castro
P, Shao L, Sreekumar A, Putluri N, Guha N, Deepak S, et al: MNX1 Is
oncogenically upregulated in African-American prostate cancer.
Cancer Res. 76:6290–6298. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Das M: MNX1: A novel prostate cancer
oncogene. Lancet Oncol. 17:e5212016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xie JJ, Zhuo YJ, Zheng Y, Mo RJ, Liu ZZ,
Li BW, Cai ZD, Zhu XJ, Liang YX, He HC and Zhong WD: High
expression of ASPM correlates with tumor progression and predicts
poor outcome in patients with prostate cancer. Int Urol Nephrol.
49:817–823. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schlomm T: Re: The molecular taxonomy of
primary prostate cancer. Eur Urol. 69:11572016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cancer Genome Atlas Research Network, .
The molecular taxonomy of primary prostate cancer. Cell.
163:1011–1025. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Buyyounouski MK, Choyke PL, McKenney JK,
Sartor O, Sandler HM, Amin MB, Kattan MW and Lin DW: Prostate
cancer-major changes in the American Joint Committee on Cancer
eighth edition cancer staging manual. CA Cancer J Clin. 67:245–253.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rees MA, Resnick MI and Oesterling JE: Use
of prostate-specific antigen, Gleason score, and digital rectal
examination in staging patients with newly diagnosed prostate
cancer. Urol Clin North Am. 24:379–388. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dirks WG and Drexler HG: STR DNA typing of
human cell lines: Detection of intra- and interspecies
cross-contamination. Methods Mol Biol. 946:27–38. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nabzdyk CS, Chun M, Pradhan Nabzdyk L,
Yoshida S and LoGerfo FW: Differential susceptibility of human
primary aortic and coronary artery vascular cells to RNA
interference. Biochem Biophys Res Commun. 425:261–265. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tusher VG, Tibshirani R and Chu G:
Significance analysis of microarrays applied to the ionizing
radiation response. Proc Natl Acad Sci USA. 98:pp. 5116–5121. 2001;
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Taylor BS, Schultz N, Hieronymus H,
Gopalan A, Xiao Y, Carver BS, Arora VK, Kaushik P, Cerami E, Reva
B, et al: Integrative genomic profiling of human prostate cancer.
Cancer Cell. 18:11–22. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yin H, Meng T, Zhou L, Chen H and Song D:
SPC24 is critical for anaplastic thyroid cancer progression.
Oncotarget. 8:21884–21891. 2017.PubMed/NCBI
|
|
25
|
Pathania R, Ramachandran S, Mariappan G,
Thakur P, Shi H, Choi JH, Manicassamy S, Kolhe R, Prasad PD, Sharma
S, et al: Combined Inhibition of DNMT and HDAC blocks the
tumorigenicity of cancer stem-like cells and attenuates mammary
tumor growth. Cancer Res. 76:3224–3235. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tsaur I, Hennenlotter J, Oppermann E, Munz
M, Kuehs U, Stenzl A and Schilling D: PCA3 and PSA gene activity
correlates with the true tumor cell burden in prostate cancer lymph
node metastases. Cancer Biomark. 15:311–316. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Prensner JR, Rubin MA, Wei JT and
Chinnaiyan AM: Beyond PSA: The next generation of prostate cancer
biomarkers. Sci Transl Med. 4:127rv32012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wan X, Yang S, Huang W, Wu D, Chen H, Wu
M, Li J, Li T and Li Y: UHRF1 overexpression is involved in cell
proliferation and biochemical recurrence in prostate cancer after
radical prostatectomy. J Exp Clin Canc Res. 35:342016. View Article : Google Scholar
|
|
29
|
D'Amico AV, Whittington R, Malkowicz SB,
Wu YH, Chen M, Art M, Tomaszewski JE and Wein A: Combination of the
preoperative PSA level, biopsy gleason score, percentage of
positive biopsies, and MRI T-stage to predict early PSA failure in
men with clinically localized prostate cancer. Urology. 55:572–577.
2000. View Article : Google Scholar : PubMed/NCBI
|
